Yeh Y P, Luh D L, Chang S H, Suo J, Chang H J, Chen T H H
Taichung County Health Bureau, Taichung, Taiwan.
Trans R Soc Trop Med Hyg. 2005 Jul;99(7):509-16. doi: 10.1016/j.trstmh.2005.03.001.
We aimed to assess whether tuberculin reactivity in adults is affected by bacille Calmette-Guerin (BCG) vaccination after 50 years of universal BCG vaccination with 80-95% coverage. A community-based study on tuberculin reactivity in 619 participants was conducted in February 2000 in Keelung city, Taiwan. Information on BCG vaccination policies and annual risk of infection (ARI) in the underlying population was extracted from consecutive national prevalence surveys relating to the period 1952-1997. Compared with the expected ARI estimate, the standardized morbidity ratio of positive tuberculin response for vaccination in infancy was 2.2 (95% CI 0.3-15.5) for those aged <10 years. The corresponding figures for older age groups ranged from 3.6 (95% CI 2.2-5.9) for those aged 10-12 years to 0.7 (95% CI 0.5-0.9) for those aged 57-67 years. This suggests that the effect of BCG vaccination on positive tuberculin response in adults aged >30 years is probably negligible irrespective of age at vaccination or revaccination and that the tuberculin skin test can be used to diagnose TB in control programmes in countries with moderate or high incidence of TB.
在卡介苗(BCG)普遍接种覆盖率达80%-95% 50年后,我们旨在评估成人的结核菌素反应性是否受BCG接种的影响。2000年2月在台湾基隆市对619名参与者进行了一项基于社区的结核菌素反应性研究。关于BCG接种政策和潜在人群的年度感染风险(ARI)的信息,是从1952 - 1997年期间连续的全国患病率调查中提取的。与预期的ARI估计值相比,年龄<10岁的婴儿接种疫苗后结核菌素反应呈阳性的标准化发病比为2.2(95%CI 0.3 - 15.5)。老年组的相应数字范围从10 - 12岁年龄组的3.6(95%CI 2.2 - 5.9)到57 - 67岁年龄组的0.7(95%CI 0.5 - 0.9)。这表明,无论初次接种或再接种时的年龄如何,BCG接种对30岁以上成年人结核菌素反应呈阳性的影响可能微不足道,并且在结核病发病率中等或较高的国家,结核菌素皮肤试验可用于结核病控制项目中的结核病诊断。